ArticleCureus2025
Neonatal Outcome After Expectant Management of Preterm Premature Rupture of Membranes (PPROM) Between 34+0 and 36+6 Weeks of Gestation: A Single-Center Cohort Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe aim of the study was to assess adverse neonatal outcome after preterm premature rupture of membranes (PPROM) between 34+0 and 36+6 weeks of gestation in patients undergoing expectant management after PPROM according to the intrauterine inflammation, infection, or both (TRIPLE-I) criteria. STUDY
designThis retrospective analysis included 323 singleton pregnancies with PPROM between 34+0 and 36+6 weeks of gestation. Groups of cases that met at least some of the TRIPLE-I diagnostic criteria and were suspected of having TRIPLE-I were created and compared with groups of cases that did not meet these criteria.
resultsMean gestational age at time of birth was 35.9 weeks [IQR; 35.0-36.4], mean gestational age at time of PPROM was 34.7 [IQR; 34.0 -35.4], and mean birth weight was 2,660 g [IQR; 2,140-2,985]. Two hundred four (63.2%) infants were delivered vaginally, 107 (33.1%) via caesarean section and 12 (3.7%) women had vaginal operative delivery (vacuum extraction). There were only two cases of maternal fever, and no case met all TRIPLE-I diagnostic criteria. No significant increase in risks were found for low umbilical artery pH (OR: 1.88 (95% CI: 0.50-5.88), p = 0.29), low Apgar score (OR: 1.14 (95% CI: 0.17-4.73), p = 0.86), or need for neonatal admission to neonatal intensive care unit (NICU) due to infection (OR: 1.14 (95% CI: 0.17-4.73), p = 0.62) in women with elevated white blood cell count in performed logistic regressions. Same applied for cases with tachycardic cardiotocography (CTG).
conclusionExpectant management appears to be a viable and potentially safe approach for managing cases of PPROM between 34+0 and 36+6 weeks of gestation, without significantly increasing the risk of adverse neonatal outcome. However, close monitoring, personalized care and readiness to intervene are important for optimally managing these clinical cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.